• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Xylem Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Costs Associated with Exit or Disposal Activities

    1/30/25 4:18:06 PM ET
    $XYL
    Fluid Controls
    Industrials
    Get the next $XYL alert in real time by email
    xyl-20250128
    0001524472false00015244722025-01-282025-01-28
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, DC 20549
    FORM 8-K
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): January 28, 2025
    XYLEM INC.
    (Exact name of registrant as specified in its charter)
    Indiana001-3522945-2080495
    (State or other jurisdiction
    of incorporation)
    (Commission
    File Number)
    (IRS Employer
    Identification No.)
    301 Water Street SE20003
    WashingtonDC
    (Address of principal executive offices)(Zip Code)
    (202) 869-9150
    (Registrant’s telephone number, including area code)
    (Former name or former address, if changed since last report)

    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange of which registered
    Common Stock, par value $0.01 per shareXYLNew York Stock Exchange

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    ☐Emerging growth company
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨



    Item 2.02Results of Operations and Financial Condition

    On January 30, 2025, Xylem Inc. (the “Company”) confirmed that its financial results for the quarter and year ended December 31, 2024 will be largely in line with or above guidance for the quarter and year ended December 31, 2024 that was provided by the Company in its earnings announcement on October 31, 2024.

    This information in this Item 2.02 of this report is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

    Item 2.05Cost Associated with Exit or Disposal Activities
    On January 28, 2025, at the delegation of the Company’s Board of Directors, management committed to a restructuring plan. The plan consists of workforce reductions across all of our businesses and functions. Consistent with our 2024 Investor Day highlights around simplification to achieve our strategy, this plan is designed to streamline our organization, which will strengthen our competitive positioning and ability to better serve our customers. The majority of the workforce reductions are expected to be completed during fiscal year 2025 with some completing in 2026, subject to local laws.
    As a result of this restructuring, the Company currently expects to incur pre-tax charges of approximately $95 million to $115 million primarily during 2025, with some charges expected in 2026, and inclusive of approximately $19 million in the fourth quarter of 2024. The expected charges are comprised of employee severance, termination benefits, and associated costs, to be paid in cash. The estimated charges and the timing of such charges are based on certain assumptions, including local legal requirements and completion of consultations with works councils in various jurisdictions. We may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur as a result of or in connection with the implementation of the planned workforce reductions. As a result, the actual timing and costs of the restructuring may differ from the Company’s current expectations and estimates.

    This Current Report on Form 8-K contains “forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” "contemplate," "predict," “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” "potential," "may" and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions, goals, or restructuring and business optimization plans; or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth. Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results, to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the Company’s ability to retain and attract leadership, key talent and other qualified employees; competition for overall talent and labor; the timing and implementation of restructuring; uncertainty around the costs and savings related to restructuring; deterioration of general macroeconomic conditions; challenges with transforming and growing our business; compliance with relevant laws; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 and in subsequent filings we make with the Securities and Exchange Commission.

    All forward-looking statements made herein are based on information currently available to us as of the date of this Current Report on Form 8-K. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.




    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
    XYLEM INC.
    Date: January 30, 2025By:/s/ William K. Grogan
    William K. Grogan
    Senior Vice President & Chief Financial Officer
    (Authorized Officer of Registrant)



    Get the next $XYL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $XYL

    DatePrice TargetRatingAnalyst
    5/30/2025$148.00Overweight
    Analyst
    12/12/2024Outperform → Peer Perform
    Wolfe Research
    12/9/2024$135.00 → $148.00Neutral → Buy
    Citigroup
    9/3/2024$138.00Buy → Hold
    TD Cowen
    8/13/2024$165.00Buy
    UBS
    3/12/2024$150.00Outperform
    Exane BNP Paribas
    1/4/2024Underperform → Mkt Perform
    Raymond James
    12/13/2023$127.00Outperform
    Wolfe Research
    More analyst ratings

    $XYL
    SEC Filings

    See more
    • SEC Form SD filed by Xylem Inc.

      SD - Xylem Inc. (0001524472) (Filer)

      5/30/25 4:17:05 PM ET
      $XYL
      Fluid Controls
      Industrials
    • Xylem Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Xylem Inc. (0001524472) (Filer)

      5/16/25 4:19:30 PM ET
      $XYL
      Fluid Controls
      Industrials
    • SEC Form 10-Q filed by Xylem Inc.

      10-Q - Xylem Inc. (0001524472) (Filer)

      4/29/25 11:27:29 AM ET
      $XYL
      Fluid Controls
      Industrials

    $XYL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Analyst initiated coverage on Xylem with a new price target

      Analyst initiated coverage of Xylem with a rating of Overweight and set a new price target of $148.00

      5/30/25 8:42:01 AM ET
      $XYL
      Fluid Controls
      Industrials
    • Xylem downgraded by Wolfe Research

      Wolfe Research downgraded Xylem from Outperform to Peer Perform

      12/12/24 8:31:33 AM ET
      $XYL
      Fluid Controls
      Industrials
    • Xylem upgraded by Citigroup with a new price target

      Citigroup upgraded Xylem from Neutral to Buy and set a new price target of $148.00 from $135.00 previously

      12/9/24 8:39:56 AM ET
      $XYL
      Fluid Controls
      Industrials

    $XYL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP & President, WSS Aulick Rodney covered exercise/tax liability with 1,665 shares, decreasing direct ownership by 2% to 74,304 units (SEC Form 4)

      4 - Xylem Inc. (0001524472) (Issuer)

      5/27/25 5:01:02 PM ET
      $XYL
      Fluid Controls
      Industrials
    • Director Yadav Uday was granted 1,300 shares, increasing direct ownership by 18% to 8,626 units (SEC Form 4)

      4 - Xylem Inc. (0001524472) (Issuer)

      5/14/25 4:16:27 PM ET
      $XYL
      Fluid Controls
      Industrials
    • Director Morelli Mark D was granted 1,300 shares, increasing direct ownership by 26% to 6,298 units (SEC Form 4)

      4 - Xylem Inc. (0001524472) (Issuer)

      5/14/25 4:16:14 PM ET
      $XYL
      Fluid Controls
      Industrials

    $XYL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Tretikov Lila bought $528 worth of shares (4 units at $131.98) and sold $480 worth of shares (4 units at $119.96) (SEC Form 4)

      4 - Xylem Inc. (0001524472) (Issuer)

      12/2/24 4:16:05 PM ET
      $XYL
      Fluid Controls
      Industrials